Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs.
Thiry
Anne
A
Drug Design and Discovery Center, FUNDP, University of Namur, Namur, Belgium. anne.thiry@fundp.ac.be
Supuran
Claudiu T
CT
Masereel
Bernard
B
Dogné
Jean-Michel
JM
D000951:Antigens, Neoplasm / Q000737:chemistry / Q000502:physiology; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology; D001665:Binding Sites; D014408:Biomarkers, Tumor / Q000737:chemistry / Q000502:physiology; D000071231:Carbonic Anhydrase IX; D002257:Carbonic Anhydrase Inhibitors / Q000737:chemistry / Q000494:pharmacology; D002256:Carbonic Anhydrases / Q000737:chemistry / Q000502:physiology*; D015687:Cell Hypoxia; D006801:Humans; D007527:Isoenzymes / Q000737:chemistry / Q000502:physiology; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology*
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D002257:Carbonic Anhydrase Inhibitors; D007527:Isoenzymes; C089226:CA9 protein, human; D000071231:Carbonic Anhydrase IX; D002256:Carbonic Anhydrases; C477378:carbonic anhydrase XII